A Phase II Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia

Hagop M. Kantarjian, Bruno Lioure, Stella K. Kim, Ehab Atallah, Thibaut Leguay, Kevin Kelly, Jean Pierre Marolleau, Martine Escoffre-Barbe, Xavier G. Thomas, Jorge Cortes, Elias Jabbour, Susan O'Brien, Pierre Bories, Corina Oprea, Laurence Hatteville, Hervé Dombret

Research output: Contribution to journal › Article › peer-review

56 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase II Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences